At 22:30 on 15 December, Beijing time, Lanvin Group, a global luxury fashion 
group under Fosun, was listed on the New York Stock Exchange with the stock 
code "LANV". On the morning of 15 December, Club Med under Fosun Tourism Group 
opened Club Med Kiroro Peak in Hokkaido, Japan, which is the fifth resort newly 
opened by Club Med this year. 

Market analysts believe that Fosun is actively making strategic focus in the 
face of the constant changes in the macro environment. On 15 December, Fosun 
held the Fosun's 30th Anniversary ONE FOSUN Family Members' Carnival. At the 
internal event, Guo Guangchang, Chairman of Fosun International, shared several 
memorable moments in the 30 years since Fosun was founded in 1992 and revealed 
the future development direction of Fosun: Fosun will reinforce its positioning 
as a "family-oriented consumer group," focus on its core business strategically 
around the consumption needs of global families, and strengthen the two core 
growth engines of globalization and innovation.

In Guo Guangchang's speech on 15 December, he shared the moment of the 
successful acquisition of Club Med in 2015. "The acquisition of Club Med is an 
important milestone in Fosun's globalization history, and Club Med is our first 
brand with global significance." He said, "I believe that the significance of 
Club Med and Fosun Tourism Group is far beyond resorts, it represents a new way 
of life for families."

Fosun has been operating in the industry profoundly for nearly eight years; 
Club Med has made remarkable progress in the global market, especially in China 
and the Asia-Pacific region, with customers from 35 countries and regions. It 
has also successfully created hot-selling products in China such as Club Med 
Joyview. In the first three quarters of 2022, against the recurring epidemics, 
the business volume of Club Med reached RMB9.135 billion, representing a 
year-on-year increase of more than 145.7%, while in the peak winter travel 
season from Christmas this year to February 2023, the bookings of overseas 
resorts have increased significantly compared with the same period last year, 
and many resort rooms were sold out during the Chinese New Year. Moreover, with 
the adjusted epidemic prevention and control measures in mainland China, Club 
Med's nine resorts in China have also seen a significant increase in bookings 
and inquiries.

Club Med is just one of the many global projects that Fosun has successfully 
operated. As of now, Fosun has established profound business presence in more 
than 30 countries and regions around the world and has more than 100,000 
employees worldwide. Guo Guangchang said, "As a private enterprise founded in 
Shanghai and developed in China, I am proud to say we have one of the best 
globalization capabilities. Now that the world is facing many challenges, 
Fosun's globalization capabilities are even more valuable." Guo Guangchang also 
emphasized the importance of innovation in his speech. Based on previous 
interim reports and annual reports disclosed by Fosun International, it is 
evident that Fosun attaches great importance to innovation. In 2021, Fosun 
invested RMB8.9 billion in technology and innovation. In the first half of 
2022, despite the pressure on overall performance, Fosun still invested RMB4.6 
billion in technology and innovation, representing a year-on-year increase of 
21%.

The technological innovation capabilities that Fosun accumulated the years have 
also continued to bear fruit. For example, in the health segment, in the first 
half of this year, new and sub-new products such as Han Li Kang, Han Qu You, 
and Han Si Zhuang contributed more than 25% of Fosun Pharma's revenue. Since 
July this year, Azvudine, China's first oral medication for COVID-19 jointly 
developed by Fosun Pharma and Genuine Biotech, has been widely used in the 
prevention and control of the epidemic in various places. Recently, Fosun 
Pharma approached a number of online medical platforms for cooperation to 
improve the accessibility of Azvudine through multiple channels, so as to 
further meet the needs of home treatment of patients infected with COVID-19.

The COVID-19 mRNA vaccine, COMIRNATY® jointly developed by Fosun and BioNTech, 
a German biotechnology company, has also made continuous progress. The 
COMIRNATY® bivalent vaccine which can protect against the Omicron variant has 
been administered in Hong Kong SAR and Macao SAR on 1 December. Recently, Macao 
SAR has rolled out the self-funded COVID-19 vaccination service of COMIRNATY® 
for domestic tourists.

Guo Guangchang said, "BioNTech, a Germany biotechnology company, chose to 
cooperate with Fosun to develop the COVID-19 mRNA vaccine because they 
recognize Fosun Pharma's research and development capabilities and 
globalization strategy. Globalization and innovation are very important to 
Fosun, and they are also the core growth engines that we will continue to 
adhere to."

In recent years, Fosun continued to reinforce it's positioning as a "global 
innovation-driven consumer group" and strengthen its foothold in health, 
happiness, wealth and other business segments. Guo Guangchang said in his 
speech that, "we hope to create a better world and create happier lives for 
families worldwide. We also hope more people can live till the age of 121 with 
health, happiness and wealth."

With the strategic focus on the household consumption industry, the profound 
industry operations became particularly important. In recent years, under the 
intensive cultivation of Fosun, international brands such as Club Med, Lanvin, 
and Wolford, as well as time-honored brands including Laomiao, and Songhelou 
have all radiated new vitality.

Taking Lanvin, one of the oldest luxury brands in France as an example, in the 
first half of 2022, Lanvin delivered 117% year-on-year global sales growth, and 
Lanvin Group, its operating parent company, recorded a revenue of EUR202 
million, representing a year-on-year increase of 73%. Lanvin Group has also 
become one of the fastest growing companies in the global luxury goods 
industry. After listing on the New York Stock Exchange, Lanvin Group will usher 
a new round of development.

Looking ahead, Guo Guangchang said, "More opportunities are waiting for us. We 
must refine our products to the best, provide the best service, and offer the 
best user experience. We hope to create a better world."

Source: Fosun